BMRN: Wutah pendapatan triwulanan BioMarin Pharmaceutical

BioMarin Pharmaceutical (BMRN) - logo korporat

Risks of disruptions at plants in the US and Ireland are impacting revenue dynamics, and therefore the quarterly revenue growth figure on GURU.Markets reflects current stability, where the indicator stands at 30.10. BioMarin Pharmaceutical (BMRN) generates revenue based on government procurement of exclusive drugs, while business resilience relies on a monopoly in the treatment of rare genetic pathologies with full patient retention.

BMRN Tambahing pendapatan triwulanan BioMarin Pharma (04.07.2022 - 20.11.2026)

Ringkesan rincian data analitis BioMarin (BMRN)

- indikator dhuwit lan arus kas:
Pambiji fundamental perusahaan:biomarin.com (BMRN)
Produk sing diprodhuksi biomarin.com

For BioMarin Pharmaceutical (BMRN), which develops monopoly drugs for rare diseases, quarterly revenue growth confirms the effective commercialization of high-cost developments. This metric measures the percentage change in sales volume for the current quarter compared to the same period last year, revealing the pace of market expansion. By analyzing quarterly sales volume dynamics, an investor assesses cash flow sustainability amid high interest rates. A consistent positive trend here signals business scaling with low marginal costs.

Pesaing BioMarin Pharmaceutical

Vertex Pharmaceuticals - Wutah pendapatan triwulanan|Tambahing pendapatan triwulanan ALNY (Alnylam Pharmaceuticals)|INSM: Wutah pendapatan triwulanan|United Therapeutics Corp (UTHR) - Wutah pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal BridgeBio Pharma Inc|Wutah dodolan triwulanan BGM Group Ltd (BGM)|Wutah pendapatan kuartal marang kuartal cogentbio.com (COGT)|Wutah dodolan triwulanan Xeris Biopharma XERS|Wutah pendapatan triwulanan KROS (kerostx.com)|Wutah pendapatan triwulanan Arcturus Therapeutics Holdings Inc. ARCT|etonpharma.com - Wutah pendapatan triwulanan|KMDA - Wutah pendapatan triwulanan|FULC (Fulcrum Corp) - Wutah dodolan triwulanan|ABEO (Abeona Therapeutics, Inc.) - Wutah pendapatan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal mereobiopharma.com|PLX (Protalix BioTherapeutics, Inc.) - Owah-owahan dodolan kuartal marang kuartal|Wutah pendapatan triwulanan PLRX|Wutah pendapatan kuartal marang kuartal APLT (Applied Therapeutics)|Rein Therapeutics Inc - Wutah dodolan triwulanan|Gelteq Limited (GELS) - Tingkat wutah pendapatan sajrone kuartal|aytubio.com - Wutah pendapatan triwulanan|chemomab.com (CMMB) - Wutah dodolan triwulanan|SRXH: Wutah pendapatan triwulanan|Dinamika pendapatan kuartal marang kuartal PLRZ (Polyrizon Ltd.)|Wutah dodolan triwulanan AEZS|CYTH: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal inozyme.com (INZY)|Wutah pendapatan triwulanan Reneo Pharmaceuticals Inc. (RPHM)|Wutah pendapatan triwulanan CSCI (Aeterna Zentaris)